Recent trials support endovascular thrombectomy (EVT) in select patients beyond the conventional 6-hour window.
Objective
In this work, we estimate the impact of extended window EVT on procedural volumes and population-level clinical outcomes using Monte Carlo simulation.
Methods
We simulated extending EVT eligibility in a system comprising an EVT-incapable primary stroke center (PSC) and EVT-capable comprehensive stroke center (CSC) using routing paradigms that initially direct patients to (1) the nearest center, (2) the CSC, or (3) either CSC or nearest center based on stroke severity. EVT eligibility and outcomes are based on HERMES, DEFUSE-3, and DAWN studies in the 0-6, 6-16, and 16-24 hour windows, respectively. Probability of good clinical outcome is determined by type and timing of treatment using clinical trial data.
Results
Relative increase in EVT volume in the three tested routing paradigms was 15.7-15.8%. The absolute increase in the rate of good clinical outcome 0.4% in all routing paradigms. NNT for extended window EVT was 239.9-246.4 among the entire stroke population.
Conclusion
Extended window EVT with DEFUSE-3 and DAWN criteria increases EVT volume and modestly improves population-level clinical outcomes.
GoyalMDemchukAMMenonBK, et al.
Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med2015;
372: 1019–1030.
2.
SaverJLGoyalMBonafeA, et al.
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med2015;
372: 2285–2295.
3.
JovinTGChamorroACoboE, et al.;REVASCAT Trial Investigators.
Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med2015;
372: 2296–2306.
4.
BerkhemerOAFransenPSSBeumerD, MR CLEAN Investigatorset al.
A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med2015;
372: 11–20.
5.
CampbellBCVMitchellPJKleinigTJ, et al.
Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med2015;
372: 1009–1018.
6.
AlbersGWMarksMPKempS, et al.
Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med2018;
378: 708–718.
7.
NogueiraRGJadhavAPHaussenDC, et al.
Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med2018;
378: 11–21.
8.
PowersWJRabinsteinAAAckersonT, et al.;American Heart Association Stroke Council.
2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke2018;
49: e46–e110.
9.
HeldnerMRZublerCMattleHP, et al.
National institutes of health stroke scale score and vessel occlusion in 2152 patients with acute ischemic stroke. Stroke2013;
44: 1153–1157.
10.
HeldnerMRHsiehKBroeg-MorvayA, et al.
Clinical prediction of large vessel occlusion in anterior circulation stroke: mission impossible?J Neurol2016;
263: 1633–1640.
11.
LeesKRBluhmkiEvon KummerR, et al.; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group.
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet2010;
375: 1695–1703.
12.
KatzanILHammerMDHixsonED, et al.
Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol2004;
61: 346.
13.
ReevesMKhouryJAlwellK, et al.
Distribution of national institutes of health stroke scale in the Cincinnati/Northern Kentucky stroke study. Stroke2013;
44: 3211–3213.
14.
SaverJLGoyalMvan der LugtA, HERMES Collaboratorset al.
Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA2016;
316: 1279–1288.
15.
FonarowGCSmithEESaverJL, et al.
Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association’s target: stroke initiative. Stroke2011;
42: 2983–2989.
16.
FordALWilliamsJASpencerM, et al.
Reducing door-to-needle times using Toyota’s lean manufacturing principles and value stream analysis. Stroke2012;
43: 3395–3398.
17.
MishraSMDykemanJSajobiTT, et al.
Early reperfusion rates with IV tPA are determined by CTA clot characteristics. AJNR Am J Neuroradiol2014;
35: 2265–2272.
18.
GoyalMMenonBKVan ZwamWH, et al.
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet2016;
387: 1723–1731.
19.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke. N Engl J Med1995;
333: 1581–1587.
20.
JadhavAPDesaiSMKenmuirCL, et al.
Eligibility for endovascular trial enrollment in the 6- to 24-hour time window: analysis of a single comprehensive stroke center. Stroke2018;
49: 1015–1017.
21.
ZhouMHKansagraAP.Effect of routing paradigm on patient centered outcomes in acute ischemic stroke. J Neurointerv Surg2019;
11: 762–767.
22.
MaasMBSinghalAB.Unwitnessed stroke: impact of different onset times on eligibility into stroke trials. J Stroke Cerebrovasc Dis2013;
22: 241–243.
23.
YangWKangDWGookHS, et al.
The clinical benefit and care burden of extending the window of endovascular thrombectomy for stroke in the emergency room. J Clin Neurol2019;
15: 168–174.
24.
AchitHSoudantMHosseiniK, et al.; THRACE Investigators.
Cost-effectiveness of thrombectomy in patients with acute ischemic stroke: the THRACE randomized controlled trial. Stroke2017;
48: 2843–2847.
25.
PizzoEDumbaMLobotesisK.Cost-utility analysis of mechanical thrombectomy between 6 and 24 hours in acute ischemic stroke. Int J Stroke2020;
15: 75–84.
26.
van der MeulenMPLansdorp-VogelaarIGoedeSL, et al.
Colorectal cancer: cost-effectiveness of colonoscopy versus CT colonography screening with participation rates and costs. Radiology2018;
287: 901–911.
27.
KnudsenABZauberAGRutterCM, et al.
Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US preventive services task force. JAMA2016;
315: 2595–2609.
